Laboratory data of serum NSE, sIL-2R, and ACE were available for sarcoidosis patients who had received OCS therapy due to involvement of organs including the nervous system (N = 7), lung (N = 3), heart (N = 3), kidney (N = 3), skin (N = 2), and spleen (N = 1). This evidence concerns the gene ENO2 and sarcoidosis.